265 related articles for article (PubMed ID: 16179569)
21. Sleep disturbance correlates with white matter hyperintensity in patients with subcortical ischemic vascular dementia.
Cheng CY; Tsai CF; Wang SJ; Hsu CY; Fuh JL
J Geriatr Psychiatry Neurol; 2013 Sep; 26(3):158-64. PubMed ID: 23788613
[TBL] [Abstract][Full Text] [Related]
22. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Scheltens P; Barkhof F;
Stroke; 2008 May; 39(5):1414-20. PubMed ID: 18323505
[TBL] [Abstract][Full Text] [Related]
23. Do lesions involving the cortical cholinergic pathways help or hinder efficacy of donepezil in patients with Alzheimer's disease?
Fukui T; Hieda S; Bocti C
Dement Geriatr Cogn Disord; 2006; 22(5-6):421-31. PubMed ID: 16974095
[TBL] [Abstract][Full Text] [Related]
24. Effect of white matter hyperintensity on medial temporal lobe atrophy in Alzheimer's disease.
Jang JW; Kim S; Na HY; Ahn S; Lee SJ; Kwak KH; Lee MA; Hsiung GY; Choi BS; Youn YC
Eur Neurol; 2013; 69(4):229-35. PubMed ID: 23344183
[TBL] [Abstract][Full Text] [Related]
25. White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy.
Du AT; Schuff N; Chao LL; Kornak J; Ezekiel F; Jagust WJ; Kramer JH; Reed BR; Miller BL; Norman D; Chui HC; Weiner MW
Neurobiol Aging; 2005 Apr; 26(4):553-9. PubMed ID: 15653183
[TBL] [Abstract][Full Text] [Related]
26. Automated and visual scoring methods of cerebral white matter hyperintensities: relation with age and cognitive function.
Tiehuis AM; Vincken KL; Mali WP; Kappelle LJ; Anbeek P; Algra A; Biessels GJ
Cerebrovasc Dis; 2008; 25(1-2):59-66. PubMed ID: 18033959
[TBL] [Abstract][Full Text] [Related]
27. Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.
van Straaten EC; Harvey D; Scheltens P; Barkhof F; Petersen RC; Thal LJ; Jack CR; DeCarli C;
J Neurol; 2008 Sep; 255(9):1302-8. PubMed ID: 18825439
[TBL] [Abstract][Full Text] [Related]
28. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment.
Debette S; Bombois S; Bruandet A; Delbeuck X; Lepoittevin S; Delmaire C; Leys D; Pasquier F
Stroke; 2007 Nov; 38(11):2924-30. PubMed ID: 17885256
[TBL] [Abstract][Full Text] [Related]
29. Complexity of MRI white matter hyperintensity assessments in relation to cognition in aging and dementia from the Sunnybrook Dementia Study.
Gao FQ; Swartz RH; Scheltens P; Leibovitch FS; Kiss A; Honjo K; Black SE
J Alzheimers Dis; 2011; 26 Suppl 3():379-88. PubMed ID: 21971477
[TBL] [Abstract][Full Text] [Related]
30. Cortical hubs and subcortical cholinergic pathways as neural substrates of poststroke dementia.
Lim JS; Kim N; Jang MU; Han MK; Kim S; Baek MJ; Jang MS; Ban B; Kang Y; Kim DE; Lee JS; Lee J; Lee BC; Yu KH; Black SE; Bae HJ
Stroke; 2014 Apr; 45(4):1069-76. PubMed ID: 24603067
[TBL] [Abstract][Full Text] [Related]
31. Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.
Price CC; Tanner JJ; Schmalfuss IM; Brumback B; Heilman KM; Libon DJ
J Alzheimers Dis; 2015; 48(3):833-47. PubMed ID: 26402109
[TBL] [Abstract][Full Text] [Related]
32. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
[TBL] [Abstract][Full Text] [Related]
33. Neuropsychological correlates of the proportional impact of white matter hyperintensities on mild to moderate dementia: the MRI 300 study.
Ku BD; Na DL; Moon SY; Kim SY; Seo SW; Cheong HK; Park KW; Park KH; Lee JY; Cha KR; Shim YS; Youn YC; Chung CS; Kim JE; Kang HY; Kim SY; Choi SH; Han SH
Dement Geriatr Cogn Disord; 2011; 31(6):397-405. PubMed ID: 21734395
[TBL] [Abstract][Full Text] [Related]
34. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.
Yoshita M; Fletcher E; Harvey D; Ortega M; Martinez O; Mungas DM; Reed BR; DeCarli CS
Neurology; 2006 Dec; 67(12):2192-8. PubMed ID: 17190943
[TBL] [Abstract][Full Text] [Related]
35. White matter hyperintensities in dementia: does it matter?
Wahlund LO; Basun H; Almkvist O; Andersson-Lundman G; Julin P; Sääf J
Magn Reson Imaging; 1994; 12(3):387-94. PubMed ID: 8007767
[TBL] [Abstract][Full Text] [Related]
36. Cognitive consequences of subcortical magnetic resonance imaging changes in Alzheimer's disease: comparison to small vessel ischemic vascular dementia.
Doddy RS; Massman PJ; Mawad M; Nance M
Neuropsychiatry Neuropsychol Behav Neurol; 1998 Oct; 11(4):191-9. PubMed ID: 9845410
[TBL] [Abstract][Full Text] [Related]
37. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
[TBL] [Abstract][Full Text] [Related]
38. Cholinergic subcortical hyperintensities in Alzheimer's disease patients from the Sunnybrook Dementia Study: relationships with cognitive dysfunction and hippocampal atrophy.
McNeely AA; Ramirez J; Nestor SM; Zhao J; Gao F; Kiss A; Stuss DT; Black SE
J Alzheimers Dis; 2015; 43(3):785-96. PubMed ID: 25114078
[TBL] [Abstract][Full Text] [Related]
39. Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia.
Swartz RH; Stuss DT; Gao F; Black SE
Stroke; 2008 Mar; 39(3):822-30. PubMed ID: 18258840
[TBL] [Abstract][Full Text] [Related]
40. Subcortical whiter matter hyperintensities within the cholinergic pathways of patients with dementia and parkinsonism.
Park HE; Park IS; Oh YS; Yang DW; Lee KS; Choi HS; Ahn KJ; Kim JS
J Neurol Sci; 2015; 353(1-2):44-8. PubMed ID: 25891829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
